You are currently viewing a new version of our website. To view the old version click .

Infectious Endophthalmitis: Clinical Settings, Antibiotic Susceptibility, and Visual Outcomes

Special Issue Information

Dear Colleagues,  

Infectious endophthalmitis is a rare sight-threatening intraocular infection that can occur following ocular surgery or trauma, as well as through the hematogenous spread of microorganisms from endogenous infection. Prompt administration of intravitreal antibiotics with or without pars plana vitrectomy is crucial for preventing severe vision loss. Endophthalmitis can be caused by a variety of bacterial and fungal pathogens. The development of infectious endophthalmitis can range from rapidly progressive fulminant infection to a chronic, indolent course. Management and diagnosis of intraocular infections can be challenging, and multiple factors may lead to significant ocular morbidity, which can destroy ocular tissues. 

We are pleased to invite you to submit articles related to the infectious endophthalmitis, including experimental and clinical endophthalmitis. Original research articles and reviews are welcome. Research areas may include (but are not limited to) pathogens, clinical settings, diagnosis and detection, management and outcomes, antibiotic susceptibility and resistance, and antibiotic toxicity.

We look forward to receiving your contributions.

Dr. Kuan-Jen Chen
Dr. Yi-Hsing Chen
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • bacterial endophthalmitis
  • fungal endophthalmitis
  • exogenous endophthalmitis
  • endogenous endophthalmitis
  • experimental endophthalmitis
  • antimicrobial agents
  • antibiotic susceptibility and resistance

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Antibiotics - ISSN 2079-6382